Clinical Trials Logo

Clinical Trial Summary

To evaluate and compare the relative bioavailability and therefore the bioequivalence of fixed dose combination of Metformin and Vildagliptin Tablets 850/50 mg manufactured by Oman Pharmaceuticals Products Co. LLC, Sultanate of Oman, with EUCREAS® 50/850mg tablets manufactured by Novartis Pharma GmbH, Germany, in Normal, Healthy, Adult, Male Human Subjects under Fed Conditions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05337969
Study type Interventional
Source Alfred E. Tiefenbacher (GmbH & Co. KG)
Contact
Status Completed
Phase N/A
Start date December 2015
Completion date March 2016

See also
  Status Clinical Trial Phase
Completed NCT00652600 - Bioavailability Study of Propranolol Under Fed Conditions Phase 1
Completed NCT01380496 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions Phase 1
Completed NCT00652821 - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions Phase 1
Completed NCT00652873 - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions Phase 1
Completed NCT00652704 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions Phase 1
Completed NCT00652730 - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions Phase 1
Completed NCT05329857 - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated. N/A
Completed NCT00653003 - Bioavailability Study of Leflunomide Tablets Under Fed Conditions Phase 1
Completed NCT01380431 - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study Phase 1